Thursday, August 17, 2017 11:50:35 AM
True and anyone who understood that TRTC is equity financed via convertible debt (arguably toxic terms) this is not new news.
However, the rate at which those liabilities were converted and sold into the market last quarter, thus strengthening the balance sheet, but with the expense of dilution was an interesting move. Interesting in that the PPS wasn't completely crushed. OTC is a popularity contest and TRTC is popular.
Will new convertible debt be on better terms? Can TRTC go cash flow positive with Nevada revenues?
A balance sheet risk I foresee is a goodwill impairment charge if BLUM Oakland doesn't perform, but don't see that in the cards until full year 2018 revenues of adult use in California are factored in.
The story continues, times to be in, times to be out.
IMO, a worthy gamble to be in as past common stock buyers financed what's been built.
North Bay Resources Reports Assays up to >25% Mg, 0.1% Ni, 0.1% Cu, 0.01% Co, 0.3 ppm Pt at Tulameen Platinum Project, British Columbia • NBRI • May 29, 2024 9:03 AM
One World Products, Inc. Issues Shareholder Update • OWPC • May 29, 2024 8:20 AM
Green Leaf Innovations, Inc. Engages Olayinka Oyebola & Co for Two-Year Audit • GRLF • May 28, 2024 8:30 AM
HealthLynked Introduces AI-Powered Chat Function to Enhance Healthcare Accessibility • HLYK • May 28, 2024 8:00 AM
Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM